Metformin Use May Moderate the Effect of DPP-4 Inhibitors on Cardiovascular Outcomes.
Matthew J CrowleyJohn W WilliamsAndrzej S KosinskiDavid A D'AlessioJohn B BusePublished in: Diabetes care (2017)
Baseline metformin status may have a moderating effect on cardiovascular outcomes with DPP-4i use. This hypothesis-generating analysis suggests there is residual uncertainty as to how DPP-4i affect cardiovascular outcomes, depending on concurrently prescribed medications.
Keyphrases